Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients
Philipp Schütt, Birgit Schütt, Magdalena Switala, et al.
Human Immunology (2010) Vol. 71, Iss. 5, pp. 489-495
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, et al.
Journal of Thoracic Oncology (2010) Vol. 6, Iss. 4, pp. 824-833
Open Access | Times Cited: 312
The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
Antonino Bruno, Chiara Focaccetti, Arianna Pagani, et al.
Neoplasia (2013) Vol. 15, Iss. 2, pp. 133-IN7
Open Access | Times Cited: 215
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
Antonino Bruno, Guido Ferlazzo, Adriana Albini, et al.
JNCI Journal of the National Cancer Institute (2014) Vol. 106, Iss. 8, pp. 1-13
Open Access | Times Cited: 169
The role of classical and non-classical HLA class I antigens in human tumors
Juergen Bukur, Simon Jasinski, Barbara Seliger
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 350-358
Closed Access | Times Cited: 160
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, et al.
Cellular and Molecular Life Sciences (2010) Vol. 68, Iss. 3, pp. 417-431
Open Access | Times Cited: 133
Role of Distinct Natural Killer Cell Subsets in Anticancer Response
Helena Stabile, Cinzia Fionda, Angela Gismondi, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 129
Molecular Pathways: Human Leukocyte Antigen G (HLA-G)
Giuseppe Curigliano, Carmen Criscitiello, Lucia Gelao, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 20, pp. 5564-5571
Closed Access | Times Cited: 120
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients
Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann, et al.
Human Immunology (2016) Vol. 77, Iss. 9, pp. 791-799
Closed Access | Times Cited: 76
The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases
Fabrício C. Dias, Erick C. Castelli, Cristhianna V. A. Collares, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 71
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
HLA-dependent tumour development: a role for tumour associate macrophages?
Maddalena Marchesi, Emilia Andersson, Lisa Villabona, et al.
Journal of Translational Medicine (2013) Vol. 11, Iss. 1
Open Access | Times Cited: 66
Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer
Mathilde Allard, Romain Oger, Virginie Vignard, et al.
PLoS ONE (2011) Vol. 6, Iss. 6, pp. e21118-e21118
Open Access | Times Cited: 61
HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas
Marianne J. Rutten, Frederike Dijk, C. Dilara Savci-Heijink, et al.
Journal of Immunology Research (2014) Vol. 2014, pp. 1-11
Open Access | Times Cited: 54
Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
Aifen Lin, Xia Zhang, Wenjun Zhou, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 6, pp. 1382-1390
Open Access | Times Cited: 58
Human leukocyte antigen-G in cancer: Are they clinically relevant?
Wei‐Hua Yan
Cancer Letters (2011) Vol. 311, Iss. 2, pp. 123-130
Closed Access | Times Cited: 58
Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention
Martin R. Jadus, Josephine Natividad, Anthony Mai, et al.
Clinical and Developmental Immunology (2012) Vol. 2012, pp. 1-21
Open Access | Times Cited: 51
The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells
Lu Liu, Lijun Wang, Lihong Zhao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 37
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis
Jorge Bartolomé, Consolación Molto, Javier David Benítez Fuentes, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease?
Angela Dardano, Roberta Rizzo, Antonio Polini, et al.
The Journal of Clinical Endocrinology & Metabolism (2012) Vol. 97, Iss. 11, pp. 4080-4086
Open Access | Times Cited: 39
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: A candidate molecule for therapeutic intervention and prognostic biomarker?
Fabrícia Gimenes, Jorge Juarez Vieira Teixeira, André Luelsdorf Pimenta de Abreu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 576-589
Closed Access | Times Cited: 35
Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences
Elaheh Emadi, Fatemeh Akhoundi, Seyed Mehdi Kalantar, et al.
BMC Genomic Data (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages
Chandra Kirana, Andrew Ruszkiewicz, Richard S. Stubbs, et al.
International Journal of Cancer (2017) Vol. 140, Iss. 11, pp. 2577-2586
Open Access | Times Cited: 31
Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer
Lidy Vannessa Mejía-Guarnizo, Paula Stefanny Monroy-Camacho, Daniel Esteban Rincón-Rodríguez, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top